What is the current Inhibikase Therapeutics share price?
The current share price of Inhibikase Therapeutics is US$ 2.25
How many Inhibikase Therapeutics shares are in issue?
Inhibikase Therapeutics has 67,192,570 shares in issue
What is the market cap of Inhibikase Therapeutics?
The market capitalisation of Inhibikase Therapeutics is USD 147.82M
What is the 1 year trading range for Inhibikase Therapeutics share price?
Inhibikase Therapeutics has traded in the range of US$ 1.12 to US$ 4.20 during the past year
What is the PE ratio of Inhibikase Therapeutics?
The price to earnings ratio of Inhibikase Therapeutics is -7.87
What is the cash to sales ratio of Inhibikase Therapeutics?
The cash to sales ratio of Inhibikase Therapeutics is 571.79
What is the reporting currency for Inhibikase Therapeutics?
Inhibikase Therapeutics reports financial results in USD
What is the latest annual turnover for Inhibikase Therapeutics?
The latest annual turnover of Inhibikase Therapeutics is USD 261k
What is the latest annual profit for Inhibikase Therapeutics?
The latest annual profit of Inhibikase Therapeutics is USD -19.03M
What is the registered address of Inhibikase Therapeutics?
The registered address for Inhibikase Therapeutics is 1313 N MARKET ST STE 5100, SUITE 101, WILMINGTON, DELAWARE, 19801
What is the Inhibikase Therapeutics website address?
The website address for Inhibikase Therapeutics is www.inhibikase.com
Which industry sector does Inhibikase Therapeutics operate in?
Inhibikase Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
![Logo of Crypviser CVCOIN [Ethereum] (CVNGBP).](/common/images/company/COIN_CVNUSD.png){kind=small}
